Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 49.03B | 46.52B | 59.82B | 54.11B | 48.16B | 47.70B |
Gross Profit | 4.95B | 4.58B | 5.80B | 5.08B | 4.32B | 3.83B |
EBITDA | 4.00B | 4.73B | 5.49B | 4.92B | 4.28B | 3.68B |
Net Income | 2.27B | 2.05B | 2.70B | 2.26B | 1.75B | 1.42B |
Balance Sheet | ||||||
Total Assets | 51.70B | 49.50B | 44.44B | 41.99B | 42.54B | 41.54B |
Cash, Cash Equivalents and Short-Term Investments | 8.79B | 9.42B | 9.31B | 7.10B | 5.94B | 4.64B |
Total Debt | 9.12B | 9.10B | 9.66B | 10.42B | 12.30B | 13.36B |
Total Liabilities | 22.00B | 21.27B | 19.98B | 20.50B | 22.87B | 23.37B |
Stockholders Equity | 29.71B | 28.23B | 24.46B | 21.49B | 19.67B | 18.17B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.41B | 3.36B | 3.52B | 2.90B | 2.75B |
Operating Cash Flow | 0.00 | 3.91B | 5.24B | 4.52B | 3.69B | 3.63B |
Investing Cash Flow | 0.00 | -2.67B | -2.01B | -784.00M | -612.00M | -1.03B |
Financing Cash Flow | 0.00 | -1.38B | -1.23B | -2.45B | -1.68B | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥10.79B | 8.09 | 3.74% | 4.70% | 8.98% | ||
80 Outperform | ¥22.52B | 8.03 | 0.75% | 3.89% | -45.94% | ||
77 Outperform | ¥8.21B | 7.00 | 2.07% | -1.74% | 36.79% | ||
76 Outperform | ¥13.73B | 9.86 | 3.63% | 4.04% | -13.19% | ||
76 Outperform | ¥21.80B | 12.31 | 2.51% | 18.43% | 19.44% | ||
71 Outperform | ¥17.75B | 8.15 | 2.57% | 8.45% | 6.78% | ||
65 Neutral | $10.89B | 15.56 | 5.22% | 1.87% | 3.09% | -26.84% |